tirzepatide after stopping Leads to Rebound in Weight, Cardiometabolic Risk Stopping Tirzepatide: What To Expect

How lean body mass, nutrition, and activity affect maintenance dosing Until then, our job as clinicians is to bridge the gap listening to patient experience while anchoring every decision in safety and physiology

Chronic adrenergic stimulation induces brown adipose tissue differentiation in visceral adipose tissue

Allen, G.F., Toth, R., James, J

Validation of the zebrafish pentylenetetrazol seizure model: locomotor versus electrographic responses to antiepileptic drugs

Which State Medicaid Programs Currently Cover GLP-1 Drugs

Stool preparation under anaerobic conditions contributes to retention of obligate anaerobes: potential improvement for fecal microbiota transplantation